The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of novel three peptides combination with gemcitabine as a first-line therapy for advanced pancreatic cancer (VENUS-PC study).
 
Hiroaki Tanaka
No Relationships to Disclose
 
Nobuaki Suzuki
No Relationships to Disclose
 
Haruo Iguchi
No Relationships to Disclose
 
Kazuhiro Uesugi
No Relationships to Disclose
 
Kosei Hirakawa
No Relationships to Disclose
 
Ryosuke Amano
No Relationships to Disclose
 
Atsushi Aruga
No Relationships to Disclose
 
Takashi Hatori
No Relationships to Disclose
 
Ishizaki Hidenobu
No Relationships to Disclose
 
Yuzo Umeda
No Relationships to Disclose
 
Mitsuo Shimada
No Relationships to Disclose
 
Kazuhiko Yoshimatsu
No Relationships to Disclose
 
Ryoichi Shimizu
No Relationships to Disclose
 
Hiroaki Ozasa
No Relationships to Disclose
 
Hiroto Hayashi
No Relationships to Disclose
 
Koichiro Sakata
No Relationships to Disclose
 
Tomio Ueno
No Relationships to Disclose
 
Hiroyuki Furukawa
No Relationships to Disclose
 
Shoichi Hazama
No Relationships to Disclose
 
Masaaki Oka
No Relationships to Disclose